Frost & Sullivan is to host a webinar on stem cell therapy pipeline and treatments innovating regenerative medicine
Webinar: Why Stem Cell Therapy?
The webinar will take place online at 4pm BST on Tuesday, 22 September 2015.
Frost & Sullivan said that the webinar intends to give insight into the stem cell therapy market, including its size and projected growth, the current state and future trends of the industry, funding and partnerships within the stem cell therapy market and centers of excellence and venture capital.
Frost & Sullivan’s transformational health senior consultant, Jane Andrews, said: “Stem cell therapy is a new and rapidly growing industry showing phenomenal potential in its ability to be operated alone or in combination with gene and immunotherapy to cure diseases.
“A key barrier to market growth is manufacturing, aside from regulatory concerns, it is difficult to efficiently scale up production. The cost of goods sold for autologous production is very high and practical quality process engineering is badly needed for both autologous and allogeneic production to increase profit margins to acceptable levels.”
To attend the briefing, email Anna Zanchi, corporate communications – anna.zanchi@frost.com - your full name, job title, company name, company telephone number, and company email address, website, city and country.